For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250926:nRSZ0714Ba&default-theme=true
RNS Number : 0714B Beacon Rise Holdings PLC 26 September 2025
26 September 2025
BEACON RISE HOLDINGS PLC
("Beacon Rise" or the "Company")
Update in relation to issuance of shares
and
Total voting rights
On 24 April 2025, the board of directors (the "Board") of Beacon Rise
announced the issuance of 120,000 new ordinary shares of £1.00 each in the
share capital of the Company (the "Ordinary Shares") at a price of £1.50 per
new Ordinary Share (the "Issue Price").
It has since come to the Company's attention that while the 120,000 new
Ordinary Shares have validly been allotted by the Board, the Board did not at
the time make an application (i) to the UK's Financial Conduct Authority (the
"FCA") for the admission of the 120,000 new Ordinary Shares to trading on the
equity shares (shell companies) category of the Official List of the FCA; and
(ii) to trading on the London Stock Exchange Plc (the "LSE") main market for
listed securities (together the "Application").
On 19 September 2025, the Company separately announced the proposed issuance
of 250,000 new Ordinary Shares at a price of £1.60 per new Ordinary Share to
raise in aggregate gross proceeds of £0.4 million (the "Proposed Fundraise").
In accordance with the requirements of the UK Prospectus Regulation, the
Company is currently prohibited from issuing more than 20 per cent of its
issued share capital during any preceding twelve-month period without the
publication of a prospectus. As a result of the Application, the Company will
have limited authorities remaining under the exemptions available under the UK
Prospectus Regulation to issue new Ordinary Shares. In light of this, and as
part of the Proposed Fundraise the Company will now only be seeking the
admission of only 111,149 new Ordinary Shares at a price of £1.60 per new
Ordinary Share, raising in aggregate gross proceeds of approximately £0.18
million.
The Company is currently exploring a number of alternative options in relation
to structuring the balance of the Proposed Fundraise. This includes taking
into account the new Public Offers and Admissions to Trading Regulations 2024,
which will replace the UK Prospectus Regulation and is expected to be
implemented on 19 January 2026. The Company will provide a further update in
due course.
Admission
In light of the above, application will now be made: (i) to the FCA for the
admission of the 231,149 new Ordinary Shares to trading on the equity shares
(shell companies) category of the Official List of the FCA; and (ii) to the
LSE for the admission of the 231,149 new Ordinary Shares to trading on its
main market for listed securities (together, "Admission"). Admission is
expected to take place at 8.00 a.m. on or around 1 October 2025.
Total voting rights
Immediately following Admission, the Company will have 1,411,482 ordinary
shares of £1.00 each in issue, each with one voting right. There are no
shares held in treasury. Therefore, the Company's total number of ordinary
shares in issue and voting rights will be 1,411,482 and this figure may be
used by shareholders from Admission as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, the Company under the FCA's Disclosure Guidance
and Transparency Rules.
Enquiries:
Xiaobing Wang, Director
Beacon Rise Holdings Plc
Email: info@beaconrise.uk
LDC Nominee Secretary Limited, Company Secretary
Email: beaconrisecss@lawdeb.com
Legal Entity Identifier (LEI): 2138007PIYMZMBWD4M27
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOEZQLFLEKLEBBE